Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
نویسندگان
چکیده
منابع مشابه
Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
Purpose To assess the effectiveness and safety of intravitreal aflibercept in clinically significant diabetic macular edema (DME) in daily clinical practice. Methods Prospective, open-label, single-center study. Anti-vascular endothelial growth factor naïve patients with clinically significant DME received intravitreal injections of aflibercept 2 mg, five monthly doses followed by a fixed sch...
متن کاملThe clinical utility of aflibercept for diabetic macular edema
The treatment of center-involving diabetic macular edema (DME) has improved because of the proven efficacy of drugs that inhibit the effects of vascular endothelial growth factor (VEGF). The newest anti-VEGF drug, aflibercept, has recently been approved by the United States Food and Drug Administration for the treatment of center-involving DME and for diabetic retinopathy in eyes with DME. In t...
متن کاملMultifocal electroretinogram in clinically significant diabetic macular edema.
OBJECTIVE To explore the multifocal electroretinogram in patients with nonproliferative diabetic retinopathy with clinically-significant macular edema. METHODS Forty-one eyes with clinically significant macular edema were tested. The latencies and amplitudes of average responses of 5 eccentric rings from 0 to 26 degrees relative to the fixation point were compared with normal values obtained ...
متن کامل[Clinically significant diabetic macular edema: systemic risk factors].
OBJECTIVE We examined the influence of non-ophthalmic parameters as risk factors of clinically significant macular edema (CSME). METHODS The authors reviewed clinical records of all clinically significant macular edema between 1995 and 2005. The association between the presence of CSME and HgbA1c, onset and duration of diabetes, blood pressure, body mass index, lipid status, sex, tobacco smok...
متن کاملOCT Classification of Clinically Significant Macular Edema
Diabetic macular edema is the commonest cause of visual loss in patients with non proliferative diabetic retinopathy and a common cause of visual loss in PDR. According to Early Treatment Diabetic Retinopathy study, early detection and laser treatment of clinically significant macular oedema decreases the risk of moderate visual loss by 50%. Though laser has been the standard of care till recen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Ophthalmology
سال: 2018
ISSN: 1177-5483
DOI: 10.2147/opth.s154421